CLINICAL_TRIALS
trial_result
· 2017-04-25
Clinical Trial Update: A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration [Phase 2]
Summary
This clinical trial update reports the Phase 2 results of abicipar pegol in Japanese patients with neovascular age-related macular degeneration.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2017-04-25